Christy Foreman is taking an associate director role in FDA’s Center for Tobacco Products, leaving a vacancy at the top of the Office of Device Evaluation. CDRH Chief Scientist William Maisel will fill in while the device center seeks a replacement.

CDRH Deputy Center Director for Policy Nancy Stade will leave the agency at the end of the summer.

The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.